Skip to main content
Caplight Logo









Beyond Pharmaceutical Co., Ltd.

Beyond Pharmaceutical Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttp://www.beyond-pharma.com/

Last Round

M&A

Feb 22, 2024

Est. Valuation

$1.2B

Total Funding Raised

$91.43M

Company Overview

Beyond Pharmaceutical Co., Ltd. is a specialty chemical and pharmaceutical company that provides chemistry and manufacture solutions, including custom synthesis, advanced intermediates, and catalog products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

pharmaceutical intermediatescustom synthesisCDMOcontract chemical manufacturingspecialty chemicalsfine chemicalschemical building blocksorganometallic catalystsheterocyclic compoundsGrubbs catalystmedicinal chemistryprocess developmentchemical supplierdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beyond Pharmaceutical Co., Ltd. Comparables

Compare Beyond Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.

Beyond Pharmaceutical Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Amadis Chemical Co., Ltd.
82%
Nanjing Chemlin Chemical Industry Co., Ltd.
81%
Bide Pharmatech Co., Ltd.
81%

Beyond Pharmaceutical Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AFeb 22, 2024
Private PlacementAug 7, 2023
VC RoundJul 17, 2023
IPONov 8, 2019
Growth EquityJan 7, 2019
Series A
Aug 1, 2017

Beyond Pharmaceutical Co., Ltd. Investors

Notable investors and investment history

Beyond Pharmaceutical Co., Ltd. investors
InvestorRounds
Janus Henderson GroupPrivate Placement
RA Capital ManagementPrivate Placement
TCG CrossoverPrivate Placement
Oriza HoldingsSeries B
Ming BioventuresVC Round
OrbiMedPrivate Placement
Logos CapitalPrivate Placement

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 7, 2023

    $100M round led by Vivo Capital

  • Jul 17, 2023

    Led by Ming Bioventures.

Beyond Pharmaceutical Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Beyond Pharmaceutical Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersHangzhou
Year Founded2014
Last FundingFeb 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?